Advertisement

Journal of Endocrinological Investigation

, Volume 6, Issue 4, pp 297–300 | Cite as

Effects of pharmacological doses of testosterone and dihydrotestosterone on the hypothalamic-pituitary axis function of Klinefelter patients

  • G. Forti
  • P. L. Vannucchi
  • A. Borghi
  • G. Giusti
  • S. Fusi
  • M. Serio
Comment

Abstract

Six patients affected by Klinefelter’s syndrome (KS) were treated with testosterone propionate (TP) 100 mg im daily for 4 days and one month later the same patients received dihydrotestosterone propionate (DHTP) 100 mg im daily for 4 days. Plasma levels of LH, FSH, PRL, testosterone (T) and dihydrotestosterone (DHT) have been measured in these patients for8 days during and afterTP and DHTP treatment. TP administration reduced LH levels only transiently, while a more prolonged reduction was observed for FSH. DHTP administration produced a late and transient reduction of LH and a very late reduction of FSH. PRL levels increased significantly during and after TP administration. Our data suggest that in Klinefelter patients: i) DHT is less effective than T in suppressing gonadotropin concentrations, ii) the increased PRL levels observed during and afterTP administration are not due to a pure androgenic effect, but are probably related to an increased conversion rate of T to estradiol.

Key-words

Klinefelter’s syndrome hypothalamic-pituitary axis testosterone dihydrotestosterone gonadotropins prolactin LH feed-back 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Capell P.T., Paulsen C.A., Derleth D., Skoglund R., Plymate S. The effect of short-term testosterone administration on serum FSH, LH and testosterone levels: evidence for selective abnormality in LH control in patients with Klinefelter’s syndrome. J. Clin. Endocrinol. Metab. 37:752, 1973.PubMedCrossRefGoogle Scholar
  2. 2.
    Wang C., Baker H.W.G., Burger H.G., de Kretser D.M., Hudson B. Hormonal studies in Klinefelter’s syndrome. Clin. Endocrinol. (Oxf.) 4: 399, 1975.CrossRefGoogle Scholar
  3. 3.
    Fukutani K., Isurugu K., Takayasu H., Wakabayashi K., Tamaoki B. Effects of depot testosterone therapy on serum levels of luteinizing hormone and follicle stimulating hormone in patients with Klinefelter’s syndrome and hypogonado-tropic eunuchoidism. J. Clin. Endocrinol. Metab. 39: 856, 1974.PubMedCrossRefGoogle Scholar
  4. 4.
    Forti G., Borghi A., Giusti G., Pazzagli M., Giannotti P., Mannelli M., Fusi S., Serio M. Klinefelter’s syndrome: effects of short-term testosterone administration on hypothalamic pituitary axis function. J. Endocrinol. Invest. 1: 239, 1978.PubMedCrossRefGoogle Scholar
  5. 5.
    Hagen C., McNeilly A.S., Arroe M., Emmertsen K., Fro-Iand A. Prolactin levels in gynaecomastia related to Klinefelter’s syndrome. Lancet 2: 57, 1974.PubMedCrossRefGoogle Scholar
  6. 6.
    Forti G., Giusti G., Borghi A., Pazzagli M., Fiorelli G., Calabresi E., Mannelli M., Bassi F., Giannotti P., Fusi S., Serio M. Klinefelter’s syndrome: a study of its hormonal plasma pattern. J. Endocrinol. Invest. 1:149, 1978.PubMedCrossRefGoogle Scholar
  7. 7.
    Burman K.D., Dimond R.C., Noel G.L., Earl J.M., Frantz A.G., Wartofsky L. Klinefelter’s syndrome: examination of thyroid function and the TSH and PRL responses to Thyrotropin-Releasing-Hormone, prior to and after testosterone administration. J. Clin. Endocrinol. Metab. 41:1161, 1975.PubMedCrossRefGoogle Scholar
  8. 8.
    Spitz I.M., Zylber E., Cohen H., Almaliach U., Leroith D. Impaired prolactin response to Thyrotropin-Releasing-Hormone in isolated gonadotropin deficiency and exaggerated response in primary testicular failure. J. Endocrinol. Metab. 48: 941, 1979.CrossRefGoogle Scholar
  9. 9.
    Winters S.J., Sherins R., Loriaux L.D. Studies on the role of sex steroids in the feed-back control of gonadotropin concentrations in men. III. Androgen resistance in primary gonadal failure. J. Clin. Endocrinol. Metab. 48: 553, 1979.PubMedCrossRefGoogle Scholar
  10. 10.
    Bassi F., Giusti G., Borsi L., Cattaneo S., Giannotti P., Forti G., Pazzagli M., Vigiani C., Serio M. Plasma androgens in women with hyperprolactinaemic amenorrhea. Clin. Endocrinol. (Oxf.) 6: 5, 1977.CrossRefGoogle Scholar
  11. 11.
    Forti G., Pazzagli M., Calabresi E., Fiorelli G., Serio M. Radioimmunoassay of plasma testosterone. Clin. Endocrinol. (Oxf.) 4: 513, 1975.CrossRefGoogle Scholar
  12. 12.
    Pazzagli M., Forti G., Cappellini A., Serio M. Radioimmunoassay of plasma dihydrotestosterone in normal and hypogonadal men. Clin. Endocrinol. (Oxf.) 4: 513, 1975.CrossRefGoogle Scholar
  13. 13.
    Loriaux D.L., Vigersky R.A., Marynick S.P., Janick J.J., Sherins R. Androgen and estrogen effects in the regulation of LH in man. In: Troen P., Nankin H.R. (Eds.), The testis in normal and infertile men. Raven Press, New York, 1977, p. 213.Google Scholar
  14. 14.
    D’Agata R., Gulizia S., Vicari E., Aliffi A., Polosa P. Effects of androgens on prolactin (PRL) release in humans. Acta Endocrinol. (Kbh.) 90: 409, 1979.Google Scholar
  15. 15.
    Spitz I.M., Halperin Y., Shilo S., Leroith D., Zylber-Haran E., Livshin Y., Laufer N., Shenker J. Clomiphene attenuates the exaggerated prolactin response to Thyrotropin-Relasing-Hormone and meto-clopramide occurring in primary testicular failure. J. Clin. Endocrinol. Metab. 52: 289, 1981.PubMedCrossRefGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1983

Authors and Affiliations

  • G. Forti
    • 1
  • P. L. Vannucchi
    • 1
  • A. Borghi
    • 1
  • G. Giusti
    • 1
  • S. Fusi
    • 1
  • M. Serio
    • 1
  1. 1.Istituto di EndocrinologiaUniversità di FirenzeFirenzeItaly

Personalised recommendations